IBOV 177,158.86 ▲ 1.88% IPSA 11,030.67 ▲ 0.87% IPC MEX 67,290.40 ▲ 1.22% MERVAL 3,304,918 ▲ 2.22% COLCAP 2,342.44 ▲ 1.64% BVL PERÚ 57,107.38 — — USD/BRL5.06▼ 1.10% USD/MXN17.34▼ 0.53% USD/CLP925.97▼ 0.82% USD/COP3,116▼ 2.96% USD/PEN3.38▼ 0.57% USD/ARS1,489▼ 0.47% USD/UYU40.22▲ 1.47% USD/PYG5,941▲ 0.68% USD/BOB11.80▲ 5.19% USD/DOP57.95▲ 0.09% USD/CRC449.30▲ 1.51% USD/GTQ7.63▲ 2.33% USD/HNL26.76▲ 0.31% USD/NIO36.62▼ 0.15% USD/VES743.77▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.39▲ 0.40% USD/TTD6.75▲ 1.19% EUR/BRL5.83▼ 0.33% BRENT 87.80 ▼ 1.38% WTI 82.26 ▼ 1.59% IRON ORE 161.91 — — COPPER 6.49 ▲ 0.71% GOLD 4,135 ▲ 0.85% SILVER 58.76 ▼ 0.10% SOY 1,194 ▲ 1.38% CORN 468.75 ▲ 5.16% WHEAT 657.50 ▼ 0.90% COFFEE 324.50 ▼ 0.40% SUGAR 14.44 ▼ 0.41% ORANGE JUICE 145.95 ▲ 5.80% COTTON 81.10 ▲ 3.95% COCOA 5,118 ▼ 1.29% BEEF 227.45 ▼ 0.20% CATTLE 342.60 ▼ 0.49% LITHIUM 69.81 ▲ 4.60% PETR4 42.84 ▲ 2.00% VALE3 76.09 ▲ 1.39% ITUB4 42.74 ▲ 2.20% BBDC4 18.39 ▲ 0.22% ABEV3 15.96 ▲ 0.38% BBAS3 21.19 ▲ 1.97% B3SA3 15.63 ▲ 2.02% WEGE3 46.82 ▲ 2.59% PRIO3 59.96 ▲ 2.65% SUZB3 42.73 ▲ 1.02% RENT3 38.23 ▲ 2.11% AZZA3 15.86 ▼ 1.80% CSAN3 3.99 ▲ 2.57% RAIZ4 0.26 — 0.00% PCAR3 2.74 ▼ 2.49% GMAT3 3.98 ▲ 2.31% PSSA3 54.35 ▲ 1.00% CVCB3 1.30 ▲ 1.56% POSI3 3.52 ▼ 0.85% SLCE3 13.26 ▲ 1.30% NATU3 8.33 ▲ 0.73% BRKM5 5.93 ▲ 3.67% RANI3 8.03 ▲ 0.88% CSNA3 4.95 ▼ 4.81% CMIN3 5.72 ▼ 4.35% USIM5 7.55 ▼ 9.25% GGBR4 24.98 ▲ 0.77% ENEV3 26.15 ▲ 1.08% CPFE3 46.09 ▲ 2.90% CMIG4 11.23 ▲ 2.09% EQTL3 38.66 ▲ 2.22% LREN3 13.52 ▲ 1.20% VIVT3 32.63 ▲ 0.28% RAIL3 14.28 ▲ 2.37% KLABIN 18.05 ▲ 0.17% RAIA DROGASIL 18.25 ▲ 2.76% RDOR3 34.42 ▲ 1.68% HAPV3 11.01 ▲ 4.36% FLRY3 16.97 ▲ 0.83% SMTO3 14.40 ▲ 0.91% UGPA3 32.92 ▲ 2.88% VBBR3 35.63 ▲ 2.98% BBSE3 40.86 ▼ 0.15% BPAC11 56.62 ▲ 3.59% CURY3 30.40 ▲ 5.37% AERI3 2.13 ▲ 0.95% VIVARA 22.16 ▼ 0.85% COMPASS 24.84 ▲ 2.60% VAMOS 3.42 ▲ 3.32% SANB11 25.25 ▼ 1.48% ASAI3 8.41 ▲ 1.33% SBSP3 27.41 ▲ 3.01% WALMEX 50.34 ▲ 1.78% GMEXICO 212.28 ▲ 2.66% FEMSA 219.70 ▲ 3.56% CEMEX 20.72 ▲ 0.63% GFNORTE 200.90 ▲ 2.13% BIMBO 60.71 ▲ 1.25% TELEVISA 9.94 ▲ 0.81% AMX 21.99 ▲ 0.73% GAP 380.75 ▲ 0.24% ASUR 276.56 ▲ 1.69% OMA 233.94 ▲ 0.55% KOF 189.04 ▲ 1.18% GRUMA 268.28 ▲ 0.39% KIMBER 40.34 ▼ 0.25% SQM-B 63,290 ▼ 0.80% COPEC 6,300 ▲ 1.78% BSANTANDER 80.70 ▲ 0.57% FALABELLA 6,220 ▲ 0.06% ENELAM 87.65 ▲ 1.11% CENCOSUD 1,945 ▲ 1.35% CMPC 1,030 ▼ 0.49% BANCO CHILE 196.80 ▲ 3.04% LATAM AIR 24.90 ▲ 2.05% YPF 81,400 ▲ 2.04% GGAL 8,015 ▲ 2.82% PAMPA 5,525 ▲ 2.89% TXAR 648.00 ▼ 1.52% ALUAR 979.00 ▲ 0.62% TGS 9,820 ▲ 3.26% CEPU 2,407 ▲ 5.06% MIRGOR 16,725 ▲ 1.06% COME 44.75 ▲ 4.95% LOMA NEGRA 3,690 ▲ 0.48% BYMA 299.00 ▲ 0.34% TELECOM ARG 4,355 ▲ 1.52% ECOPETROL 17.04 ▲ 3.90% BANCOLOMBIA 93.89 ▲ 4.94% GRUPO AVAL 5.17 ▲ 5.41% CREDICORP 402.27 ▲ 4.78% SOUTHERN COPPER 185.00 ▲ 5.43% BUENAVENTURA 31.86 ▲ 5.43% MERCADOLIBRE 1,886 ▲ 1.20% NUBANK 14.49 ▲ 3.21% XP 17.20 ▲ 5.46% PAGSEGURO 9.84 ▲ 3.14% STONE 11.43 ▲ 4.29% GLOBANT 36.39 ▼ 4.61% TECNOGLASS 43.59 ▼ 2.87% GAP AIRPORT 219.58 ▲ 1.20% ASUR 276.56 ▲ 1.69% OMA AIRPORT 108.09 ▲ 1.61% AMX ADR 25.33 ▲ 1.85% FEMSA ADR 126.76 ▲ 4.71% CEMEX ADR 11.94 ▲ 2.01% PETROBRAS ADR 19.12 ▲ 2.85% VALE ADR 14.99 ▲ 2.32% ITAU ADR 8.44 ▲ 3.56% SANTANDER BR 5.06 ▲ 1.29% AMBEV ADR 3.12 ▲ 0.65% CSN 1.01 ▼ 2.43% GERDAU 4.96 ▲ 2.06% LATAM ADR 53.94 ▲ 3.63% BTC 64,188 ▲ 0.44% ETH 1,901 ▼ 0.37% SOL 74.00 ▲ 0.55% XRP 1.08 ▲ 0.67% BNB 586.75 ▲ 2.69% ADA 0.17 ▲ 4.99% DOGE 0.07 ▼ 0.16% AVAX 6.41 ▼ 0.17% LINK 8.34 ▲ 0.24% DOT 0.76 ▲ 0.05% LTC 45.29 ▼ 0.27% BCH 214.45 ▲ 1.57% TRX 0.33 ▲ 0.88% XLM 0.17 ▼ 0.96% HBAR 0.07 ▲ 0.25% NEAR 1.64 ▲ 1.06% ATOM 1.27 ▼ 1.18% AAVE 99.24 ▲ 3.32% SELIC 14.25% EMBRAER 86.14 ▲ 0.06% EMBRAER ADR 68.11 ▲ 0.67% JBS 14.29 ▲ 0.42% JBS BDR 72.15 ▼ 0.32% MBRF3 17.96 ▲ 7.80% MBRFY 3.47 ▲ 9.12% INTER 5.64 ▲ 4.25% IBOV 177,158.86 ▲ 1.88% IPSA 11,030.67 ▲ 0.87% IPC MEX 67,290.40 ▲ 1.22% MERVAL 3,304,918 ▲ 2.22% COLCAP 2,342.44 ▲ 1.64% BVL PERÚ 57,107.38 — — USD/BRL 5.06 ▼ 1.10% USD/MXN 17.34 ▼ 0.56% USD/CLP 925.97 ▼ 0.82% USD/COP 3,116 ▼ 2.96% USD/PEN 3.38 ▼ 0.57% USD/ARS 1,489 ▼ 0.47% USD/UYU 40.22 ▲ 1.47% USD/PYG 5,941 ▲ 0.68% USD/BOB 11.80 ▲ 5.19% USD/DOP 57.95 ▲ 0.09% USD/CRC 449.30 ▲ 1.51% USD/GTQ 7.63 ▲ 2.33% USD/HNL 26.76 ▲ 0.31% USD/NIO 36.62 ▼ 0.15% USD/VES 743.77 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.39 ▲ 0.60% USD/TTD 6.75 ▲ 1.33% EUR/BRL 5.83 ▼ 0.33% BRENT 87.80 ▼ 1.38% WTI 82.26 ▼ 1.59% IRON ORE 161.91 — — COPPER 6.49 ▲ 0.71% GOLD 4,135 ▲ 0.85% SILVER 58.76 ▼ 0.10% SOY 1,194 ▲ 1.38% CORN 468.75 ▲ 5.16% WHEAT 657.50 ▼ 0.90% COFFEE 324.50 ▼ 0.40% SUGAR 14.44 ▼ 0.41% ORANGE JUICE 145.95 ▲ 5.80% COTTON 81.10 ▲ 3.95% COCOA 5,118 ▼ 1.29% BEEF 227.45 ▼ 0.20% CATTLE 342.60 ▼ 0.49% LITHIUM 69.81 ▲ 4.60% PETR4 42.84 ▲ 2.00% VALE3 76.09 ▲ 1.39% ITUB4 42.74 ▲ 2.20% BBDC4 18.39 ▲ 0.22% ABEV3 15.96 ▲ 0.38% BBAS3 21.19 ▲ 1.97% B3SA3 15.63 ▲ 2.02% WEGE3 46.82 ▲ 2.59% PRIO3 59.96 ▲ 2.65% SUZB3 42.73 ▲ 1.02% RENT3 38.23 ▲ 2.11% AZZA3 15.86 ▼ 1.80% CSAN3 3.99 ▲ 2.57% RAIZ4 0.26 — 0.00% PCAR3 2.74 ▼ 2.49% GMAT3 3.98 ▲ 2.31% PSSA3 54.35 ▲ 1.00% CVCB3 1.30 ▲ 1.56% POSI3 3.52 ▼ 0.85% SLCE3 13.26 ▲ 1.30% NATU3 8.33 ▲ 0.73% BRKM5 5.93 ▲ 3.67% RANI3 8.03 ▲ 0.88% CSNA3 4.95 ▼ 4.81% CMIN3 5.72 ▼ 4.35% USIM5 7.55 ▼ 9.25% GGBR4 24.98 ▲ 0.77% ENEV3 26.15 ▲ 1.08% CPFE3 46.09 ▲ 2.90% CMIG4 11.23 ▲ 2.09% EQTL3 38.66 ▲ 2.22% LREN3 13.52 ▲ 1.20% VIVT3 32.63 ▲ 0.28% RAIL3 14.28 ▲ 2.37% KLABIN 18.05 ▲ 0.17% RAIA DROGASIL 18.25 ▲ 2.76% RDOR3 34.42 ▲ 1.68% HAPV3 11.01 ▲ 4.36% FLRY3 16.97 ▲ 0.83% SMTO3 14.40 ▲ 0.91% UGPA3 32.92 ▲ 2.88% VBBR3 35.63 ▲ 2.98% BBSE3 40.86 ▼ 0.15% BPAC11 56.62 ▲ 3.59% CURY3 30.40 ▲ 5.37% AERI3 2.13 ▲ 0.95% VIVARA 22.16 ▼ 0.85% COMPASS 24.84 ▲ 2.60% VAMOS 3.42 ▲ 3.32% SANB11 25.25 ▼ 1.48% ASAI3 8.41 ▲ 1.33% SBSP3 27.41 ▲ 3.01% WALMEX 50.34 ▲ 1.78% GMEXICO 212.28 ▲ 2.66% FEMSA 219.70 ▲ 3.56% CEMEX 20.72 ▲ 0.63% GFNORTE 200.90 ▲ 2.13% BIMBO 60.71 ▲ 1.25% TELEVISA 9.94 ▲ 0.81% AMX 21.99 ▲ 0.73% GAP 380.75 ▲ 0.24% ASUR 276.56 ▲ 1.69% OMA 233.94 ▲ 0.55% KOF 189.04 ▲ 1.18% GRUMA 268.28 ▲ 0.39% KIMBER 40.34 ▼ 0.25% SQM-B 63,290 ▼ 0.80% COPEC 6,300 ▲ 1.78% BSANTANDER 80.70 ▲ 0.57% FALABELLA 6,220 ▲ 0.06% ENELAM 87.65 ▲ 1.11% CENCOSUD 1,945 ▲ 1.35% CMPC 1,030 ▼ 0.49% BANCO CHILE 196.80 ▲ 3.04% LATAM AIR 24.90 ▲ 2.05% YPF 81,400 ▲ 2.04% GGAL 8,015 ▲ 2.82% PAMPA 5,525 ▲ 2.89% TXAR 648.00 ▼ 1.52% ALUAR 979.00 ▲ 0.62% TGS 9,820 ▲ 3.26% CEPU 2,407 ▲ 5.06% MIRGOR 16,725 ▲ 1.06% COME 44.75 ▲ 4.95% LOMA NEGRA 3,690 ▲ 0.48% BYMA 299.00 ▲ 0.34% TELECOM ARG 4,355 ▲ 1.52% ECOPETROL 17.04 ▲ 3.90% BANCOLOMBIA 93.89 ▲ 4.94% GRUPO AVAL 5.17 ▲ 5.41% CREDICORP 402.27 ▲ 4.78% SOUTHERN COPPER 185.00 ▲ 5.43% BUENAVENTURA 31.86 ▲ 5.43% MERCADOLIBRE 1,886 ▲ 1.20% NUBANK 14.49 ▲ 3.21% XP 17.20 ▲ 5.46% PAGSEGURO 9.84 ▲ 3.14% STONE 11.43 ▲ 4.29% GLOBANT 36.39 ▼ 4.61% TECNOGLASS 43.59 ▼ 2.87% GAP AIRPORT 219.58 ▲ 1.20% ASUR 276.56 ▲ 1.69% OMA AIRPORT 108.09 ▲ 1.61% AMX ADR 25.33 ▲ 1.85% FEMSA ADR 126.76 ▲ 4.71% CEMEX ADR 11.94 ▲ 2.01% PETROBRAS ADR 19.12 ▲ 2.85% VALE ADR 14.99 ▲ 2.32% ITAU ADR 8.44 ▲ 3.56% SANTANDER BR 5.06 ▲ 1.29% AMBEV ADR 3.12 ▲ 0.65% CSN 1.01 ▼ 2.43% GERDAU 4.96 ▲ 2.06% LATAM ADR 53.94 ▲ 3.63% BTC 64,188 ▲ 0.44% ETH 1,901 ▼ 0.37% SOL 74.00 ▲ 0.55% XRP 1.08 ▲ 0.67% BNB 586.75 ▲ 2.69% ADA 0.17 ▲ 4.99% DOGE 0.07 ▼ 0.16% AVAX 6.41 ▼ 0.17% LINK 8.34 ▲ 0.24% DOT 0.76 ▲ 0.05% LTC 45.29 ▼ 0.27% BCH 214.45 ▲ 1.57% TRX 0.33 ▲ 0.88% XLM 0.17 ▼ 0.96% HBAR 0.07 ▲ 0.25% NEAR 1.64 ▲ 1.06% ATOM 1.27 ▼ 1.18% AAVE 99.24 ▲ 3.32% SELIC 14.25% EMBRAER 86.14 ▲ 0.06% EMBRAER ADR 68.11 ▲ 0.67% JBS 14.29 ▲ 0.42% JBS BDR 72.15 ▼ 0.32% MBRF3 17.96 ▲ 7.80% MBRFY 3.47 ▲ 9.12% INTER 5.64 ▲ 4.25%
since 2009
Friday, July 31, 2026

Latest News Brazil

In Severe Cases, Coronavirus Can Remain in Body System for 21 Days

By · April 23, 2020 · 3 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – Patients who suffered the most severe form of Covid-19, a disease caused by Sars-Cov-2, had the virus in their system for a longer period than those who had mild cases of infection.

In samples taken from the respiratory tract (phlegm and saliva) of more severe patients in China, the virus was found for 21 days on average. In some cases, this period extended to 30 days. The average lifespan of the virus in patients without complications was 14 days.

Patients who suffered the most severe form of Covid-19, a disease caused by Sars-Cov-2, had the virus in their system for a longer period than those who had mild cases of infection.
Patients who suffered the most severe form of Covid-19, a disease caused by Sars-Cov-2, had the virus in their system for a longer period than those who had mild cases of infection. (Photo internet reproduction)
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

The results stem from a study published by Chinese scientists on Tuesday, April 21st, in the BMJ (formerly known as The British Medical Journal), one of the most prestigious publications in the health field.

The research was conducted with more than 3,400 samples of secretions from the respiratory tract, urine, blood and feces of 96 patients seen at a hospital in Zhejiang, eastern China province. All participants in the study had Covid-19 confirmed by molecular tests (RT-PCR). Scientists classified 22 of the cases as moderate and 74 as severe.

Testing of samples showed that in patients with mild cases of the disease, the peak viral load occurs in the second week of infection. In patients with more severe cases, the amount of the virus in the body remained high in the third week of the disease.

“Everything suggests that the greater the viral load, the greater the chance of the patient developing the disease more severely. The potential for virus transmission also increases,” says Fabrizio Romano, an otorhinolaryngologist and president of the Brazilian Academy of Rhinology (ABR).

“This is one of the reasons why we see so many health professionals with Covid-19 complications, because they deal with greater proximity to more severe patients,” the doctor says.

In the most critical cases, the system fails to fight the infection and, thus, the virus is able to multiply in the body of the infected patient for longer, Romano explains.

“When these patients are discharged and go home, that doesn’t mean they have stopped passing on the disease. They must remain isolated until the test shows that the virus is no longer present,” he says.

The virus was also detected in stool samples from 59 percent of patients for an average period of 22 days – that is, longer than the virus is present in the respiratory system. Only one research participant had the virus detected in a urine sample.

According to Marco Aurélio Sáfadi, infectologist at the Faculty of Medical Sciences of Santa Casa de São Paulo, the scenario is particularly delicate when dealing with children or elderly people who need diaper changes, for instance.

The article does not provide the certainty of transmission through contact with excretions, since the molecular test, conducted to detect the disease in patients who participated in the research, identifies parts of the virus in the person, but does not determine whether it is still active to cause the infection. However, the study’s result shows that there is potential for transmission through this route, according to Sáfadi.

In the Chinese study, samples were taken from adult patients between the months of January and March this year. Sáfadi is currently conducting a study on children infected with the novel coronavirus, and the virus was also found in stool samples from younger children. The results have not yet been published.

“We cannot assume there is infectivity, but it is plausible that there is. This calls for greater attention,” says the infectologist.

According to Romano, the study conducted in China had reliable methodology, but would yield even more accurate results with the inclusion of a larger number of patients. The combination of drugs used by the participants in the research is another limitation pointed out by the doctor.

In the study, patients were administered corticoids, antibiotics or a combination of these drugs. All were treated with an antiviral drug. “We should be cautious before extrapolating these results to other populations that are given other medications,” says Romano.

Source: Folhapress

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.